Navigation Links
ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
Date:4/23/2012

ST. LOUIS, April 23, 2012 /PRNewswire/ -- ulrich medical USA, Inc., today announced the release of the Omni VBR™ Implant System, a new titanium vertebral body replacement device that is intended for use in the thoracic and lumbar spine (T1-L5) to replace a collapsed, damaged or unstable vertebral body due to tumor or trauma. 

The Omni VBR implant joins a distinguished and growing portfolio of expandable cage technologies that ulrich medical USA currently has available for purposes of vertebral body replacement: obelisc® Implant System, ADDplus™ Implant System, Small VBR® Implant System and Large VBR® Implant System.   

"We are very pleased to introduce our fifth expandable corpectomy cage to the US market with the introduction of the Omni VBR implant. Expandable VBR technology is our core competency and we will continue to support, develop and defend our market leadership position in this sector of the complex spine market moving forward," said new hire Tom Carter, Senior Marketing Manager, ulrich medical USA.

The Omni VBR features a large central lumen that allows for maximum bone grafting while maintaining the expandability that has made ulrich's cages a market leader. This product currently has a variety of endplate angulation options, is sterile-packed and available in the following diameters: 19mm, 22mm, 26mm and 30mm with expansion ranges between 10 - 131mms.

For more information, please visit www.ulrichmedicalusa.com

About ulrich medical USA, Inc.

ulrich medical USA, Inc. is a privately-held subsidiary of ulrich medical® Inc., an innovative medical technology company headquartered in Ulm, Germany which is celebrating its 100th year in business in 2012.

Company Contact:
e
'/>"/>

SOURCE ulrich medical USA, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
2. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Medical Device Developers - Network at BIOMEDevice Boston Next Week
5. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
6. KPMG Survey: Medical Device Execs Say New Excise Tax Will Hit Their Company Bottom Lines Hard
7. Hypertension Drug Adherence Associated with Fewer Hospitalizations and Lower Medical Costs but Increased Total Care Costs
8. Solta Medical to Report First Quarter 2012 Results Release and Host Conference Call on May 1
9. genae Appoints Chief Medical Officer
10. UCSF Medical Center Treats Patients with New Brainlab Curve™ Image Guided Surgery
11. Puritan Medical Products Company Launches New Diagnostic Collection and Transport Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... NEW YORK , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer ... the board of directors of Advaxis, Inc. ("Advaxis" or ... the board has breached its fiduciary duties to shareholders. ... published on an investing website reporting that Advaxis had ...
(Date:1/23/2015)... 2015  iMD Companies, Inc. (ICBU) has repositioned itself as a ... grab a foothold in the hydroponic, hemp and medical marijuana ... presence in the sector, and recently partnering with the Chippewa ... and medical marijuana, iMD is committing to bring its vision ...
(Date:1/23/2015)... MONMOUTH JUNCTION, N.J. , Jan. 23, 2015 ... immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber ... surgery patients, announced the receipt of $385,642, net ... approved participant of the Technology Business Tax Certificate ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... /PRNewswire/ -- Sirion Therapeutics,announced today that data on ... ST-602 (fenretinide), will be,presented at the 2007 annual ... Ophthalmology (ARVO) in Ft. Lauderdale, FL.,In addition to ... for ARVO attendees. , ST-601 (difluprednate) is currently ...
... 11:00 a.m. Eastern Time, LONDON, April 24, 2007 ... today announces,top-line results from its two Phase III ... The Company conducted two Phase,III double-blind, placebo-controlled studies ... placebo or 2 grams (1 gram twice,daily) of ...
Cached Medicine Technology:Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 2Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 3Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 4Amarin Reports Top-Line Results of two Phase III Studies of,Miraxion in Huntington's Disease 2Amarin Reports Top-Line Results of two Phase III Studies of,Miraxion in Huntington's Disease 3Amarin Reports Top-Line Results of two Phase III Studies of,Miraxion in Huntington's Disease 4Amarin Reports Top-Line Results of two Phase III Studies of,Miraxion in Huntington's Disease 5
(Date:1/22/2015)... (PRWEB) January 22, 2015 Woodloch Pines, an ... has been selected by TripAdvisor as the number one best ... 6th best in the world for their annual Travelers’ Choice ... travel community . The website is home to millions of ...
(Date:1/22/2015)... January 23, 2015 VogueQueen is a seasoned ... prices and many designers are thrilled to have it lead ... announces its new collection of prom dresses for the global ... drive the strategic vision and he focuses on continuing the ...
(Date:1/22/2015)... 22, 2015 Blue Cross and Blue Shield ... exemplify what it means to “Live Fearless.” , ... to share their stories about how they or someone they ... others by living in the moment. By telling these types ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and ... Merchandise Show to bestow a Juvent Sports Achievement award ... Arlene McKitrick. The award commemorated and congratulated McKitrick for ... She won her first amateur tournament in 1979 and ...
(Date:1/22/2015)... January 22, 2015 Autocarinsurancebest.com has released a ... a commercial auto insurance policy . , Auto insurance ... vehicles. It is no longer necessary to call an agent ... now available online on a single website: http://autocarinsurancebest.com/ . ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Commercial Auto Insurance Provides Several Important Features! 2
... , MONDAY, March 21 (HealthDay News) -- Surgery ... with facial paralysis who can,t completely close their eyes, according ... an eye means a loss of protection for the cornea, ... corneal ulceration, and potentially permanent vision loss," wrote Dr. Douglas ...
... HealthDay Reporter , MONDAY, March 21 (HealthDay News) -- ... worst cases of potentially life-threatening blood clots that form in ... break loose and travel to the lungs, causing a pulmonary ... United States more than 250,000 people are hospitalized for deep ...
... MONDAY, March 21 (HealthDay News) -- While the majority of ... generally satisfied years later, almost 40 percent are saddled with ... removed, a small, new Belgian study reveals. The finding ... the University of California, San Francisco that suggested gastric bypass ...
... YORK (Mar. 21, 2011) -- A new study published ... University of California, Davis, foresees improvements in patient outcomes ... information technology. A control tower-style telemedicine hub to manage ... could boost the likelihood that critically injured victims will ...
... , MONDAY, March 21 (HealthDay News) -- People appear ... suffering injuries in a traffic crash than after other ... the study, Gareth Jones, of the University of Aberdeen ... looked at 2,069 people who provided information about musculoskeletal ...
... is enrolling patients in a federally funded study to determine ... disease. "The question is, if you have kidney disease, ... Mulloy, Chief of the GHSU Section of Nephrology and a ... SPRINT, funded by the National Institutes of Health. ...
Cached Medicine News:Health News:Severe Blood Clots Should be Treated Aggressively: Heart Docs 2Health News:Severe Blood Clots Should be Treated Aggressively: Heart Docs 3Health News:40% of Gastric Banding Patients Have Complications 2Health News:40% of Gastric Banding Patients Have Complications 3Health News:40% of Gastric Banding Patients Have Complications 4Health News:Health information technology 'control tower' could improve earthquake response 2Health News:Chronic Pain Often Follows Car Crash: Study 2Health News:Study examines whether lower blood pressure reduces kidney disease progression 2
The PHOS method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of phosphorus in serum....
For the quantitative in vitro determination of total and direct bilirubin in serum or plasma....
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum...
For the quantitative in vitro determination of IgA in serum and plasma. This product is suitable for use on Hitachi 704, 705, 717, 902, 911 and 912....
Medicine Products: